TQB2930 Injection

· Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQB2930 Injection, covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Studies of TQB2930 Injection for the Treatment of Advanced Solid Tumors [Phase 1, Phase 2]